Teva noted it is the first and only digital rescue inhaler indicated in patients four years or older for the treatment or prevention of bronchospasm who have reversible obstructive airway disease ...

“The results from these Phase 3 trials support the clinical benefit of PT027, an albuterol/budesonide rescue inhaler, which has the potential to be a first-in-class treatment approach that can ...

But similar reforms to Medicaid included in the American Rescue Plan backfired. Last winter, GSK discontinued one of its top inhalers, Flovent, rather than pay new Medicaid penalties. The ...